Clinical Department

Department of Cardiovascular Medicine

Offering the latest in cardiology care for our patients and outstanding training programs for clinicians and researchers.

Cardiovascular Medicine at Wake Forest University School of Medicine has 34 cardiologists focused on caring for heart patients, leading their field in research and teaching the cardiologists of tomorrow.

Our physicians are nationally renowned leaders, researchers and educators with extensive experience in advanced cardiac care, including:

Heart transplants
Heart valve replacements
Treatment of cardiovascular disease
Heart attacks
Congestive heart failure
Congenital heart problems

Wake Forest Baptist Medical Center serves 2.3 million people in its 24-county referral area. Cardiovascular Services supports 80 cardiology beds, including 22 cardiovascular intensive care unit (ICU) beds, and offers five inpatient cardiology services. The department provides collaborative services with Wake Forest Baptist Medical Center critical care and works in collaboration with the W. G. (Bill) Hefner VA Medical Center at their Salisbury and Kernersville campuses.

Cardiovascular Sciences Center

The Cardiovascular Sciences Center (CVSC) provides key coordination and support services for Wake Forest University School of Medicine investigators engaged in cardiovascular science research, and there is a special emphasis on prevention of primary and secondary cardiovascular disease and of heart failure.

Learn More

Cardiovascular Sciences Center

The vision of the Hypertension and Vascular Research Center (HVRC) is to promote excellence in basic and clinical research in hypertension and vascular diseases through a team approach that targets translation of cutting-edge scientific advances to the patient and community at large.

Learn More

Our Research

With more than $6 million of funding in the past academic year our research focuses on heart failure with preserved ejection fraction, advanced cardiac imaging and cardiac genetic epidemiology.

The faculty also participate in clinical studies of therapies and devices. New devices implanted in the Cardiac Lab and the EP Lab are studied to improve patient outcomes and treatment, speed of recovery, and provide alternatives to long-term use of medications. Therapies are studied for treatment of advanced heart failure, improving exercise tolerance as people age, lowering blood pressure to reduce risk of heart attack without increasing risk of fall, and drug therapies after procedures to optimize clinical outcomes. All faculty subspecialty groups have ongoing clinical trials, while some faculty focus on NIH funded research.